|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/47 | |
| C07K 14/75 | |||
| C07K 14/76 | |||
| C07K 14/78 | |||
| C07K 14/79 | |||
| A61K 38/04 |
| (11) | Patento numeris | 2896630 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15153373.4 |
| Europos patento paraiškos padavimo data | 2008-01-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-07-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 898347 P | 2007-01-30 | US |
| (72) |
De Groot, Anne, US
Martin, William, US
Rivera, Dan, US
|
| (73) |
Epivax, Inc.,
188 Valley Street Suite 424, Providence, RI 02909,
US
|
| (54) | REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF |
| REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF |